What is Volonte?
Volonte specializes in providing low testosterone therapy across Indiana, offering a range of affordable and effective treatment options. Their services include testosterone injection therapy, testosterone pellet therapy, and hormone replacement therapy tailored for women. The company addresses common symptoms associated with hormonal imbalances, such as low energy, weight gain, and reduced libido. Volonte provides comprehensive medical evaluations and develops personalized treatment plans, emphasizing the importance of free testosterone screenings and consultations to enhance clients' overall health and well-being. Their commitment to quality care is reflected in positive client testimonials.
How much funding has Volonte raised?
Volonte has raised a total of $163K across 1 funding round:
Debt
$163K
Debt (2021): $163K with participation from PPP
Key Investors in Volonte
PPP
Public-Private Partnership
What's next for Volonte?
The substantial late-stage funding indicates Volonte is poised for significant expansion and market penetration. This capital infusion will likely be directed towards scaling operations, enhancing service delivery, and potentially broadening its geographical reach. Strategic investments at this stage often signal a focus on solidifying market leadership and preparing for future growth phases, possibly including further product development or strategic partnerships to optimize their hormone replacement therapy offerings.
See full Volonte company page
